Related Experiment Video
Updated: May 12, 2026
05:20
Development of a Rabbit Chronic-Like Rotator Cuff Injury Model for Study of Fibrosis and Muscular Fatty Degeneration
Published on: March 31, 2023
1.2K
Biologics in rotator cuff repair
Felix H Savoie Iii1,2, Bela P Delvadia1,2, Jackson P Tate1,2
1Department of Orthopaedic Surgery, Tulane University School of Medicine, New Orleans, Louisiana, USA.
The Bone & Joint Journal
|August 31, 2024
Summary
Rotator cuff tears often reoccur despite surgery. This review summarizes evidence on using biologics to enhance rotator cuff repair healing and reduce re-tears.
Area of Science:
- Orthopedic Surgery
- Regenerative Medicine
- Biomaterials Science
Background:
- Rotator cuff tears are prevalent in aging populations, with high re-tear rates post-surgery.
- The shoulder's healing environment is challenging, hindering effective rotator cuff tendon repair.
- Biological augmentation strategies are increasingly explored to improve surgical outcomes.
Purpose of the Study:
- To review current evidence on biological augmentation for rotator cuff tear repair.
- To assess the efficacy of biologics in enhancing rotator cuff healing.
- To evaluate the potential of biologics in reducing recurrent rotator cuff tears.
Main Methods:
- Systematic literature search for studies on biological augmentation in rotator cuff repair.
- Analysis of evidence regarding various biological agents and their application methods.
- Evaluation of clinical outcomes, including healing rates and re-tear incidence.
Main Results:
- Biologics show promise in improving the healing environment for rotator cuff tendons.
- Certain biological agents may enhance tissue integration and reduce the risk of re-tears.
- Evidence synthesis indicates a growing role for biological augmentation in optimizing repair success.
Conclusions:
- Biological augmentation is a promising adjunct to surgical rotator cuff repair.
- Further research is needed to optimize the use of specific biologics for rotator cuff healing.
- Biologics may significantly reduce re-tear rates and improve functional outcomes in patients.
Related Concept Videos
01:31Muscles that Move the Arm
Nine muscles are involved in arm movements. Two of these, the pectoralis major and latissimus dorsi, originate from the axial skeleton and are called axial muscles. The other seven originate from the scapula and are called the scapular muscles.
The pectoralis major has two origins. Its clavicular head originates on the medial half of the clavicle. In contrast, the sternocostal head originates on the costal cartilages of ribs 1-6, the sternum, and the aponeurosis of the external oblique of the...
The pectoralis major has two origins. Its clavicular head originates on the medial half of the clavicle. In contrast, the sternocostal head originates on the costal cartilages of ribs 1-6, the sternum, and the aponeurosis of the external oblique of the...
01:28Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...